The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mestecky, J. (1987) · Journal of Clinical Immunology · doi:10.1007/bf00915547 · Cited by 816
PEYER'S PATCHES: AN ENRICHED SOURCE OF PRECURSORS FOR I G A-PRODUCING IMMUNOCYTES IN THE RABBIT
Craig, S. W., & Cebra, J. J. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.134.1.188 · Cited by 755
Owen, R. L. (1977) · Gastroenterology · doi:10.1016/s0016-5085(77)80254-0 · Cited by 669
Bockman, D. E., & Cooper, M. D. (1973) · American Journal of Anatomy · doi:10.1002/aja.1001360406 · Cited by 565
A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions
Elson, C. O., Ealding, W., & Lefkowitz, J. (1984) · Journal of Immunological Methods · doi:10.1016/0022-1759(84)90089-9 · Cited by 224
Crabbé, P. A., Nash, D. R., Bazin, H., Eyssen, H., & Heremans, J. F. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.130.4.723 · Cited by 209
A study of particulate intestinal absorption and hepatocellular uptake
Sanders, E., & ASHWORTH, C. T. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90092-1 · Cited by 150
[8] Poly(lactide-co-glycolide) microcapsules for controlled release of steroids
Cowsar, D. R., Tice, T. R., Gilley, R. M., & English, J. P. (1985) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(85)12010-0 · Cited by 99
Self-citationIntestinal barrier to large particulates in mice
LeFevre, M. E., Hancock, D. C., & Joel, D. D. (1980) · Journal of Toxicology and Environmental Health · doi:10.1080/15287398009529888 · Cited by 63
Cited by
Biodegradation and biocompatibility of PLA and PLGA microspheres
Anderson, J. M., & Shive, M. S. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00048-3 · Cited by 2,617
Microplastics in bivalves cultured for human consumption
Van Cauwenberghe, L., & Janssen, C. R. (2014) · Environmental Pollution · doi:10.1016/j.envpol.2014.06.010 · Cited by 2,074
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Vaccine adjuvants: Current state and future trends
Petrovsky, N., & Aguilar, J. C. (2004) · Immunology & Cell Biology · doi:10.1111/j.0818-9641.2004.01272.x · Cited by 1,005
Functional polymer microspheres
Kawaguchi, H. (2000) · Progress in Polymer Science · doi:10.1016/s0079-6700(00)00024-1 · Cited by 947
Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
Desai, M. P., Labhasetwar, V., Amidon, G. L., & Levy, R. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016085108889 · Cited by 941
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
Jani, P., Halbert, G. W., Langridge, J., & Florence, A. T. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb07033.x · Cited by 920
Chitosan-based gastrointestinal delivery systems
Hejazi, R., & Amiji, M. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00126-3 · Cited by 882
The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent
Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., & Amidon, G. L. (1997) · Pharmaceutical Research · doi:10.1023/a:1012126301290 · Cited by 858
Biodegradation and biocompatibility of PLA and PLGA microspheres
Anderson, J. M., & Shive, M. S. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.004 · Cited by 814
Controlled drug delivery systems: Past forward and future back
Park, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.054 · Cited by 720
Hillyer, J. F., & Albrecht, R. M. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1143 · Cited by 706
Mahapatro, A., & Singh, D. K. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-55 · Cited by 685
Adjuvants—a classification and review of their modes of action
Cox, J. C., & Coulter, A. R. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00183-1 · Cited by 682
Design of biodegradable particles for protein delivery
Vila, A., Sánchez, A., Tobı́o, M., Calvo, P., & Alonso, M. J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00486-2 · Cited by 620
Jung, T. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00084-9 · Cited by 588
Hua, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00524 · Cited by 527
Singh, M., & O'Hagan, D. (1999) · Nature Biotechnology · doi:10.1038/15058 · Cited by 506
The Oral Absorption of Micro- and Nanoparticulates: Neither Exceptional Nor Unusual
Florence, A. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012029517394 · Cited by 499
Ponchel, G. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00040-4 · Cited by 494
Chitosan and its derivatives in mucosal drug and vaccine delivery
van der Lubben, I. M., Verhoef, J. C., Borchard, G., & Junginger, H. E. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00172-5 · Cited by 456
Biodegradable Polymers for Protein and Peptide Drug Delivery
Gombotz, W. R., & Pettit, D. K. (1995) · Bioconjugate Chemistry · doi:10.1021/bc00034a002 · Cited by 448
Chitosan nanoparticles for oral drug and gene delivery
Bowman, K., & Leong, K. W. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.2.117 · Cited by 439
Stealth PLA-PEG nanoparticles as protein carriers for nasal administration
Tobío, M., Gref, R., Sánchez, A., Langer, R., & Alonso, M. J. (1998) · Pharmaceutical Research · doi:10.1023/a:1011922819926 · Cited by 402
Biodegradable microspheres as a vaccine delivery system
Eldridge, J. H., Staas, J. K., Meulbroek, J. A., McGhee, J. R., Tice, T. R., & Gilley, R. M. (1991) · Molecular Immunology · doi:10.1016/0161-5890(91)90076-v · Cited by 399
Self-citationVaccination Strategies for Mucosal Immune Responses
Ogra, P. L., Faden, H., & Welliver, R. C. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.2.430-445.2001 · Cited by 390
Manjunath, K., & Venkateswarlu, V. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.006 · Cited by 380
Lipid-based formulations for intestinal lymphatic delivery
O’Driscoll, C. M. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00051-9 · Cited by 372
Eldridge, J. H., Staas, J. K., Meulbroek, J. A., Tice, T. R., & Gilley, R. M. (1991) · Infection and Immunity · doi:10.1128/iai.59.9.2978-2986.1991 · Cited by 368
Self-citationChitosan for mucosal vaccination
van der Lubben, I. M., Verhoef, J. C., Borchard, G., & Junginger, H. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00197-1 · Cited by 357
Oral delivery of proteins and peptides: Challenges, status quo and future perspectives
Zhu, Q., Chen, Z., Paul, P. K., Lu, Y., Wu, W., & Qi, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.001 · Cited by 353
Advanced drug delivery to the lymphatic system: lipid-based nanoformulations
Darwis, Y., Ali Khan, A., Mudassir, J., & Mohtar, N. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s41521 · Cited by 333
Recent developments in adjuvants for vaccines against infectious diseases
O'Hagan, D. T., MacKichan, M. L., & Singh, M. (2001) · Biomolecular Engineering · doi:10.1016/s1389-0344(01)00101-0 · Cited by 332
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination
Garinot, M., Fiévez, V., Pourcelle, V., Stoffelbach, F., des Rieux, A., Plapied, L., Theate, I., Freichels, H., Jérôme, C., Marchand-Brynaert, J., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.021 · Cited by 331
Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration
Yang, S., Zhu, J., Lu, Y., Liang, B., & Yang, C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018888927852 · Cited by 324
Rieux, A. D., Ragnarsson, E. G. E., Gullberg, E., Préat, V., Schneider, Y.-J., & Artursson, P. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.04.015 · Cited by 298
van der Lubben, I. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00231-3 · Cited by 280
Wang, R., Zhou, L., Wang, W., Li, X., & Zhang, F. (2017) · Nature Communications · doi:10.1038/ncomms14702 · Cited by 272
Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres
Blanco, M. D., & Alonso, M. J. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00056-8 · Cited by 269
Polymeric nanoparticle drug delivery technologies for oral delivery applications
Pridgen, E. M., Alexis, F., & Farokhzad, O. C. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1018175 · Cited by 269
Micro and nanoscale technologies in oral drug delivery
Ahadian, S., Finbloom, J. A., Mofidfar, M., Diltemiz, S. E., Nasrollahi, F., Davoodi, E., Hosseini, V., Mylonaki, I., Sangabathuni, S., Montazerian, H., et al. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.012 · Cited by 268
Japanese encephalitis vaccines
Halstead, S. B., & Jacobson, J. (2008) · Vaccines · doi:10.1016/b978-1-4160-3611-1.50021-0 · Cited by 264
Crowley, M. M., Schroeder, B., Fredersdorf, A., Obara, S., Talarico, M., Kucera, S., & McGinity, J. W. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.037 · Cited by 263
Li, L., Liu, T., Fu, C., Tan, L., Meng, X., & Liu, H. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.07.004 · Cited by 262
The effect of physical barriers and properties on the oral absorption of particulates
Norris, D. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00037-4 · Cited by 262
Protection Against Vaginal SIV Transmission with Microencapsulated Vaccine
Marx, P. A., Compans, R. W., Gettie, A., Staas, J. K., Gilley, R. M., Mulligan, M. J., Yamshchikov, G. V., Chen, D., & Eldridge, J. H. (1993) · Science · doi:10.1126/science.8493576 · Cited by 261
Self-citationBinding and uptake of biodegradable poly-dl-lactide micro- and nanoparticles in intestinal epithelia
McClean, S., Prosser, E., Meehan, E., O'Malley, D., Clarke, N., Ramtoola, Z., & Brayden, D. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)10007-0 · Cited by 260
Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate
Florence, A. T., Hillery, A. M., Hussain, N., & Jani, P. U. (1995) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00059-h · Cited by 260
New strategies for using mucosal vaccination to achieve more effective immunization
Walker, R. I. (1994) · Vaccine · doi:10.1016/0264-410x(94)90112-0 · Cited by 257
Lectin-mediated mucosal delivery of drugs and microparticles
Clark, M. A., Hirst, B. H., & Jepson, M. A. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00070-3 · Cited by 236
Microparticles as vaccine adjuvants and delivery systems
O’Hagan, D. T., & Singh, M. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.2.269 · Cited by 214
Shakweh, M., Besnard, M., Nicolas, V., & Fattal, E. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.04.006 · Cited by 161
M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery
Jepson, M. A., Clark, M. A., & Hirst, B. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.018 · Cited by 130
Gaumet, M., Gurny, R., & Delie, F. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.11.015 · Cited by 115
Hillery, A. M., & Florence, A. T. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04353-5 · Cited by 81
Oral Immunization with Helicobacter pylori‐Loaded Poly( d, l‐Lactide‐Co‐Glycolide) Nanoparticles
Kim, S., Doh, H., Jang, M., Ha, Y., Chung, S., & Park, H. (1999) · Helicobacter · doi:10.1046/j.1523-5378.1999.09046.x · Cited by 65
Mechanisms of uptake and transport of particulate formulations in the small intestine
Delon, L., Gibson, R. J., Prestidge, C. A., & Thierry, B. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.006 · Cited by 64
NEMOTO-KAWAMURA, C., HIRAHASHI, T., NAGAI, T., YAMADA, H., KATOH, T., & HAYASHI, O. (2004) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.50.129 · Cited by 61
Nayak, B., Panda, A. K., Ray, P., & Ray, A. R. (2009) · Journal of Microencapsulation · doi:10.1080/02652040802211709 · Cited by 57
Mucosal targeting of allergen-loaded microspheres by Aleuria aurantia lectin
Roth-Walter, F., Schöll, I., Untersmayr, E., Ellinger, A., Boltz-Nitulescu, G., Scheiner, O., Gabor, F., & Jensen-Jarolim, E. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.11.052 · Cited by 55
Torché, A.-M., Le Corre, P., Albina, E., & Le Verge, R. (1999) · Journal of Drug Targeting · doi:10.3109/10611869909085517 · Cited by 50
Gaumet, M., Gurny, R., & Delie, F. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.008 · Cited by 42
The immunopathology of M cells
Davis, I. C., & Owen, R. L. (1997) · Springer Seminars in Immunopathology · doi:10.1007/bf00824051 · Cited by 21
Metadata
- Authors
- Eldridge, J. H., Hammond, C. J., Meulbroek, J. A., Staas, J. K., Gilley, R. M., & Tice, T. R.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 1990-01
- Volume
- 11
- Issue
- 1-3
- Pages
- 205-214
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W1975133899
- Cited by
- 689
- References
- 9
- FWCI
- 20.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.